By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Foot Locker, Peloton, AMC, Nvidia, Abercrombie, Apellis, and More Market Movers
Investing

Foot Locker, Peloton, AMC, Nvidia, Abercrombie, Apellis, and More Market Movers

News Room
Last updated: 2023/08/23 at 5:39 PM
By News Room
Share
3 Min Read
SHARE

Stocks traded sharply higher Wednesday as Wall Street awaited earnings from
Nvidia,
which dominates the market for producing chips used for artificial-intelligence projects.

These stocks were making moves Wednesday: 

Foot Locker
(ticker: FL) sank 28% after slashing its fiscal-year adjusted earnings outlook to $1.30 to $1.50 a share from earlier guidance of $2 to $2.25.
Nike
(NKE) shares fell 2.7%. The stock extended its losing streak to a record 10 days.

Peloton Interactive
(PTON) plunged 23% after the at-home fitness company saw a drop in subscribers and provided a disappointing outlook for its fiscal first quarter.

AMC Entertainment
(AMC) fell 13% after declining 18% in the previous session. The movie-theater chain said that Thursday would be the last day of trading of AMC Preferred Equity units, also known as APES. APE units will be converted to common stock and result in the trading of a single class of AMC common shares. AMC also is planning a 10-for-1 reverse split of its common stock on Thursday.

Nvidia
(NVDA) rose 3.2%. Shares of the chip maker set an all-time intraday high on Tuesday but ended the session down 2.8%. The stock has risen 218% in 2023. Analysts are expecting
Nvidia
to report second-quarter earnings of $2.08 a share on revenue of $11.2 billion. Nvidia’s report is scheduled for after the closing bell Wednesday.

Abercrombie & Fitch
(ANF) soared 24% after the retailer’s second-quarter adjusted earnings handily topped estimates.

Apellis Pharmaceuticals
(APLS) jumped 30% after the biopharmaceutical company issued an update on injection kits that it supplies, and an update on rare events of retinal vasculitis reported in treatment with eye-disease drug Syfovre.
Apellis
said a “causal relationship has not been established between the structural variations in this 19-gauge filter needle and the rare events of retinal vasculitis in the real world.” The company recommended doctors immediately discontinue use of any injection kits that contain the 19-gauge filter needle and instead use kits with the 18-gauge filter needle, which already are in distribution.

Williams-Sonoma
(WSM) rose 13% after the home-furnishings company reported better-than-expected second-quarter earnings.

Grab Holdings
(GRAB) was up 11% after the Singapore-based ride-sharing and food delivery company posted second-quarter revenue that rose 77% from a year earlier.

Super Micro Computer
(SMCI) gained 7.6% after Wedbush analysts raised their recommendation on the manufacturer of information technology solutions to Neutral from Underperform but maintained their price target of $250.

Streaming giant
Netflix
(NFLX) gained 3.5% and was the top performer in the
S&P 500.
Oppenheimer analysts said paid programming and advertising should increase revenue by about 40% through fiscal 2025.

Write to Joe Woelfel at [email protected] 

Read the full article here

News Room August 23, 2023 August 23, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Forget Injections. Now You Can Just Take Pills For Weight Loss

Watch full video on YouTube

Stop paying allowances – teach kids to think like owners

Watch full video on YouTube

Zimmer Biomet Holdings, Inc. (ZBH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Robert MarcusJPMorgan Chase & Co, Research Division Good morning, everyone. I'm Robbie…

Pentagon invests $1bn in US missile motor unit of defence group L3 Harris

Unlock the White House Watch newsletter for freeYour guide to what Trump’s…

Understanding Iran: seven books that help explain the unrest

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?